| Andrea Pfeifer |
Andrea Pfeifer is the founder of AC Immune SA, a company founded in 2003, where she currently holds the title of Chief Executive Officer & Director. She is also the founder of Inventages II. Dr. Pfeifer's current jobs include Chairman at BioMedInvest AG I, Chairman at AB2 Bio SA, Independent Member-Supervisory Board at Symrise AG since 2011, and Professor at the University of Lausanne. Her former jobs include Chairman at BioMedPartners AG, Member-Supervisory Board at 2invest AG, Principal at Nestlé USA, Inc., and Head-Global Research at Nestlé Nespresso SA. Dr. Pfeifer obtained a doctorate degree from Wuerzburg Schweinfurt University of Applied Sciences in 1984. |
| Howard Donovan |
Howard Donovan is currently the Chief Human Resource Officer at AC Immune SA since 2022. Prior to this, he worked as the Head-People Services at Forum Mondial de L'Economie from 2015 to 2022. |
| Christopher Roberts |
Christopher Roberts is currently the Chief Financial Officer & Vice President at AC Immune SA since 2022. He is also a Trustee & Treasurer at Msizi Africa. Previously, he worked as a Senior Manager at Ernst & Young SA (Geneva). Mr. Roberts completed his undergraduate degree at the University of Lancaster. |
| Oliver Sol |
Oliver Sol is currently working as the VP & Head-Clinical Development at AC Immune SA. Previously, he worked as the Clinical Director at Exonhit and as the Director-Medical & Regulatory Affairs at Eurobio-Scientific SA. Dr. Sol holds a doctorate degree from Université de Paris XI Paris Sud. |
| Madiha Derouazi |
Madiha Derouazi is the founder and current Chief Executive Officer & Director of Amal Therapeutics SA, which is founded in 2012. She is also currently the Chief Scientific Officer at AC Immune SA, where she started in 2024. Dr. Derouazi has a graduate degree from the Technical University of Berlin and a doctorate degree from the Swiss Federal Institute of Technology. |
| Piergiorgio Donati |
Mr. Piergiorgio Donati is a Chief Technical Operations Officer at AC Immune SA. Mr. Donati was previously employed as a Head-CMC Program Development by Glenmark Pharmaceuticals Inc., USA, a Project Manager-Research & Development by Abiogen Pharma SpA, and a Head-Research & Development by Serono SA. He received his undergraduate degree from Technical Institute of Jiangsu. |
| Jean-Fabien Monin |
Jean-Fabien Monin is currently working as the Chief Administrative Officer at AC Immune SA since 2015. Previously, he worked as the Chief Financial Officer at bioMérieux SA from 2006 to 2009. He is a graduate of Université Paris Dauphine-PSL. |
| Douglas E. Williams |
Douglas E. Williams is currently serving as the President, Chief Executive Officer & Director at Codiak BioSciences, Inc. He is also the Chairman at AC Immune SA, Xenikos BV, and Cygnal Therapeutics, Inc. Additionally, he holds positions as a Director at Cytoimmune Therapeutics, Inc., Independent Director at Panacea Acquisition Corp. II, and Director at Stablix, Inc. In his former roles, Dr. Williams served as the Chief Executive Officer & Director at ZymoGenetics, Inc. from 2009 to 2010. He was also the Director, Chief Technology Officer & Executive VP at Immunex Corp. from 1988 to 2002. Furthermore, he held the position of Director at Array BioPharma, Inc. from 2004 to 2011, Director, Chief Scientific Officer, EVP-R&D at Seagen Inc. from 2002 to 2005, Director at Anadys Pharmaceuticals, Inc. from 2004 to 2009, and Independent Director at Ironwood Pharmaceuticals, Inc. from 2014 to 2019. Dr. Williams has a doctorate degree from the State University of New York at Buffalo and an undergraduate degree from the University of Massachusetts Lowell. |
| Nuno Mendonça |
Dr. Nuno Mendonça, MD, is a Chief Medical Officer at AC Immune SA. Dr. Mendonça was previously employed as a Senior Medical Director by Novartis Gene Therapies, Inc. He received his doctorate degree from the University of Coimbra. |
